Associated Papers
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.
Baleeiro RB et al.
Frontiers in Immunology, 2022
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens.
Holmström MO et al.
Cancers, 2020
Select a paper to view details